HUM Stock: Humana Inc. Stock Price, Analysis & Insights
Get live hum stock price $235.26, comprehensive Humana Inc. stock analysis, charts, news, and expert forecast. Real-time hum stock data and investment insights.
Loading chart...
Company Overview
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Company Information
- CEO
- James A. Rechtin
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- Employees
- 65680
Contact Information
- Website
- https://www.humana.com
- Address
- Humana Building
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 22.0)
✓ Lower volatility stock (Beta: 0.46) may provide portfolio stability
Business Model & Strategy
Humana Inc. operates in the Medical - Healthcare Plans industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO James A. Rechtin, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Healthcare Plans model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Humana Inc. competes in the Medical - Healthcare Plans within the broader Healthcare. With 28.3 billion in market capitalization, the company is positioned as a established player in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, Humana Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Humana Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Humana Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Humana Inc.
- ⚠Investors should consider how Humana Inc. fits within their overall portfolio allocation
Market Cap
28.30B
P/E Ratio
22.01
Beta
0.46
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 28.30B market capitalization
- Trading Volume: 584.67K shares traded today
- Price Range: 52-week range of $206.87 - $315.35
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for Humana Inc.
Humana Inc. (HUM) operates in the Medical - Healthcare Plans industry within the Healthcare sector. With a current market capitalization of 28.30B, the company represents a significant player in its market. The stock is currently trading at $235.26 with a negativedaily change of 0.78%.
The company's 65680 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 22.01, beta of 0.46, and 52-week price range from $206.87 to $315.35when evaluating investment opportunities.
Why Invest in Humana Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under James A. Rechtin
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.